News
IVF
0.9591
-4.09%
-0.0409
Weekly Report: what happened at IVF last week (0720-0724)?
Weekly Report · 1d ago
INVO Fertility Expands Authorized Shares to Support Financing
TipRanks · 3d ago
INVO Fertility files to sell 20M shares of common stock for holders
TipRanks · 3d ago
INVO FERTILITY - COMMITMENT AMOUNT MAY BE INCREASED TO UP TO $50 MLN - SEC FILING
Reuters · 3d ago
INVO FERTILITY - ENTERED INTO ANY MARKET PURCHASE AGREEMENT WITH ALUMNI CAPITAL LP
Reuters · 3d ago
INVO Fertility signs equity purchase agreement for up to $15 million stock sales to Alumni Capital
PUBT · 3d ago
Weekly Report: what happened at IVF last week (0713-0717)?
Weekly Report · 07/20 09:10
Weekly Report: what happened at IVF last week (0706-0710)?
Weekly Report · 07/13 09:10
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 07/07 21:05
Weekly Report: what happened at IVF last week (0629-0703)?
Weekly Report · 07/06 09:10
11 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 07/02 17:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 07/01 12:05
What's Going On With INVO Fertility Stock Monday?
Benzinga · 06/29 12:52
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 06/29 12:05
Weekly Report: what happened at IVF last week (0622-0626)?
Weekly Report · 06/29 09:10
Why INVO Fertility Stock Is Surging Friday Afternoon
Benzinga · 06/26 17:45
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 06/26 17:05
Nasdaq Falls Over 200 Points; US Goods Trade Gap Widens In May
Benzinga · 06/26 14:00
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 06/26 12:05
Market-Moving News for June 26th
Benzinga · 06/26 11:21
More
Webull provides a variety of real-time IVF stock news. You can receive the latest news about INVO Fertility, Inc through multiple platforms. This information may help you make smarter investment decisions.
About IVF
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.